Anticancer activities and cell death mechanisms of 1H-indole-2,3-dione 3-[N-(4 sulfamoylphenyl)thiosemicarbazone] derivatives

DOI: 10.26650/IstanbulJPharm.2018.414805 In this study, the cytotoxic effects of 1H-indole-2,3-dione 3-[N-(4-sulfamoylphenyl)thiosemicarbazone derivatives namely, 4a-d were evaluated using cell kinetic parameters including the cell index, mitotic index, labelling index and apoptotic index on HeLa cells taken from a human cervix carcinoma. All compounds were evaluated using cell index parameters at 5, 10, 20, 40, 80, 100 and 160 μM concentrations. As a result of this, it was seen that all 4a-d compounds were effective in different concentrations. Different cell death mechanisms were proposed for 4a-d. When all the parameters were examined, it was found that the bromine substituted 4c was the most potent antiproliferative compound in the tested compounds. The difference was significant between the control and experimental groups (p<0.01). In addition, a statistically significant difference was noted among all experimental groups (p<0.01).

[1]  A. Dixit,et al.  Assessment of 5-substituted Isatin as Surface Recognition Group: Design, Synthesis, and Antiproliferative Evaluation of Hydroxamates as Novel Histone Deacetylase Inhibitors , 2017, Pharmaceutical Chemistry Journal.

[2]  C. Supuran,et al.  Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases. , 2017, Bioorganic & medicinal chemistry.

[3]  M. Gabr,et al.  Isatin-β-thiocarbohydrazones: Microwave-assisted synthesis, antitumor activity and structure-activity relationship. , 2017, European journal of medicinal chemistry.

[4]  İ. Çetin,et al.  In vitro antiproliferative effects of nab-paclitaxel with liposomal cisplatin on MDA-MB-231 and MCF-7 breast cancer cell lines. , 2017, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[5]  Veronika F. S. Pape,et al.  Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance. , 2016, European journal of medicinal chemistry.

[6]  H. Abdel‐Aziz,et al.  Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents. , 2015, European journal of medicinal chemistry.

[7]  W. Liu,et al.  Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors , 2013, Bioorganic & Medicinal Chemistry.

[8]  İ. Çetin,et al.  The effects of anastrozole on the proliferation of FM3A cells. , 2013, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[9]  P. Pakravan,et al.  Biochemical and pharmacological characterization of isatin and its derivatives: from structure to activity , 2013, Pharmacological reports : PR.

[10]  Ambili Remesh Toxicities of anticancer drugs and its management. , 2012 .

[11]  Mingliang Liu,et al.  Synthesis and antitumor activity of 5-[1-(3-(dimethylamino)propyl)-5-halogenated-2-oxoindolin-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamides. , 2011, Bioorganic & medicinal chemistry letters.

[12]  Gergely Szakács,et al.  Synthesis, activity, and pharmacophore development for isatin-beta-thiosemicarbazones with selective activity toward multidrug-resistant cells. , 2009, Journal of medicinal chemistry.

[13]  J. Knox,et al.  Sunitinib in solid tumors , 2009, Expert opinion on investigational drugs.

[14]  D. Skropeta,et al.  Cytotoxic and anticancer activities of isatin and its derivatives: a comprehensive review from 2000-2008. , 2009, Anti-cancer agents in medicinal chemistry.

[15]  Luhua Lai,et al.  Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors. , 2006, Journal of medicinal chemistry.

[16]  Yiwei Li,et al.  Using chemopreventive agents to enhance the efficacy of cancer therapy. , 2006, Cancer research.

[17]  S. Bari,et al.  Synthesis and Antimicrobial Activity of Some New Isatin Derivatives , 2006 .

[18]  Yiwei Li,et al.  Cancer Therapy Using Chemopreventive Agents to Enhance the Efficacy of Updated , 2006 .